<DOC>
	<DOCNO>NCT03099213</DOCNO>
	<brief_summary>Primary Objective : To document tolerability patient receive study medication 12-week therapy term score system assess investigator . Secondary Objectives : - To document drug safety 12-week treatment term number Adverse Drug Reaction Serious Adverse Drug Reaction report . - To describe population treat per HOPE study indication current clinical practice ( demographic , cardiovascular risk-factors treatment initiation , concomitant treatment pattern ) .</brief_summary>
	<brief_title>An Open-label , Non-comparative Study Document Tolerability Ramipril Patients With Least One High Risk Developing Major Cardiovascular Event</brief_title>
	<detailed_description>The duration study period 8-12 week .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<criteria>Inclusion criterion : Man woman , age 55 year old . Presence high risk develop major cardiovascular event , define least one follow underlying condition : Clinical evidence coronary artery disease ( example : previous myocardial infarction [ MI ] , positive stress test significant stenosis coronary angiography , previous Percutaneous TransLuminal Coronary Angioplasty [ PTCA ] , previous Coronary Arterial Bypass Grafting [ CABG ] ) ; Clinical evidence peripheral vascular disease ( example : history intermittent claudication positive Doppler angiography , previous limb bypass surgery , previous percutaneous transluminal angioplasty , previous limb foot amputation ) ; Previous stroke ; Diabetes ( insulindependent noninsulin dependent ) least one follow cardiovascular risk factor : hypertension ( blood pressure [ BP ] &gt; 140/90 mmHg , patient antihypertensive treatment ) ; hypercholesterolemia ( total cholesterol &gt; 5.2 mmol/L [ &gt; 200 mg/dL ] ) ; low HDL cholesterol ( &lt; 0.9 mmol/L [ &lt; 3.5 mg/dL ] ) ; current cigarette smoking ; document microalbuminuria ( 30300 mg/24 hour ) ; Evidence previous vascular disease . Exclusion criterion : Patients contraindication ramipril use ( per local Ramipril Product Information ) hypersensitivity pregnancy , lactation bilateral renal stenosis Patients clinically relevant concomitant disease could compromise patient 's safety follow . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>